
Syneos Health SYNH
Quartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Syneos Health Betriebsaufwand 2011-2026 | SYNH
Betriebsaufwand Jährlich Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 4.12 B | 689 M | 680 M | 463 M | 232 M | 213 M | 200 M | 176 M | 188 M | 159 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.12 B | 159 M | 712 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
1.99 B | $ 110.24 | -2.86 % | $ 33.5 B | ||
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Waters Corporation
WAT
|
687 M | $ 289.16 | -3.79 % | $ 17.2 B | ||
|
Exagen
XGN
|
40.6 M | $ 2.68 | -3.94 % | $ 57.8 M | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 16.36 | -11.57 % | $ 176 M | ||
|
Sotera Health Company
SHC
|
309 M | $ 13.13 | -3.03 % | $ 3.73 B | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
BioNano Genomics
BNGO
|
41.3 M | $ 1.16 | 0.87 % | $ 6.32 M | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
1.89 B | $ 62.25 | -5.81 % | $ 24.3 B | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 23.53 | -4.74 % | $ 654 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 159.16 | -3.62 % | $ 7.89 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 195.51 | -1.33 % | $ 21.7 B | ||
|
Organovo Holdings
ONVO
|
23.3 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
21.9 M | - | -16.95 % | $ 1.54 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
PerkinElmer
PKI
|
1.07 B | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
21.8 M | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 8.7 | -4.92 % | $ 1.89 B | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 264.2 | -1.56 % | $ 22 B | ||
|
Psychemedics Corporation
PMD
|
11.3 M | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
13.6 M | $ 25.97 | -4.52 % | $ 33.7 M | ||
|
CareDx, Inc
CDNA
|
411 M | $ 16.78 | -3.95 % | $ 894 M | ||
|
Quotient Limited
QTNT
|
106 M | - | -11.32 % | $ 1.1 M | ||
|
Renalytix AI plc
RNLX
|
29.8 M | - | 5.66 % | $ 22.7 M | ||
|
VolitionRx Limited
VNRX
|
28.3 M | $ 0.2 | 1.87 % | $ 19.2 M | ||
|
Bioventus
BVS
|
217 M | $ 8.94 | -3.46 % | $ 596 M | ||
|
Co-Diagnostics
CODX
|
45.3 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Meridian Bioscience
VIVO
|
134 M | - | - | $ 1.49 B | ||
|
Danaher Corporation
DHR
|
6.71 B | $ 181.52 | -3.27 % | $ 129 B | ||
|
Surmodics
SRDX
|
26.4 M | - | - | $ 608 M | ||
|
ENDRA Life Sciences
NDRA
|
10.8 M | $ 4.29 | -6.54 % | $ 2.3 M |